Status:
UNKNOWN
Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes
Lead Sponsor:
Third Military Medical University
Conditions:
Taurine
Diabetes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Diabetes has become important risk factors for threatening human life and health. Lower extremity arterial occlusive are the common complications of diabetes.Sulfur amino acid is the indispensable ami...
Eligibility Criteria
Inclusion
- Male or female, age between 18-80 years old
- Type 2 diabetes
Exclusion
- Type2 diabetes with acute diabetic complications.
- Type1 diabetes.
- History of cardio-cerebral vascular events, such as congestive heart failure, myocardial infarction or stroke within 3 months.
- Hypohepatia (AST or AST is twice higher than the upper limit) or history of hepatitis or cirrhosis, hepatic encephalopathy.
- Renal insufficiency (serum creatinine 1.5 times higher than the upper limit) or history of dialysis and nephritic syndrome.
- Acute infections, tumor, severe arrhythmia, mental disorders, alcohol or medicine addiction.
- Fertile woman without contraceptives.
- Any surgical or medical conditions that significantly influence absorption, distribution, metabolism or excretion of the intervention drugs.
- Allergic to or have contraindication to the intervention drugs.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03410537
Start Date
January 1 2017
End Date
June 1 2018
Last Update
January 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The third hospital affiliated to the Third Military Medical University
Chongqing, Chongqing Municipality, China, 400042